Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
MKC-3946 blocks XBP1 mRNA splicing and exhibits cytotoxicity against AML cells
PubMed PMID: 25644580
and inhibit proliferation and migration of metastatic human breast cancer cells (IC50 ~6 µM)
GW501516 is shown to be the most potent and selective PPARα agonists known with an EC50 of 1
Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system
LY294002 - PI3K/BET Dual Inhibitor. CAS# 154447-36-6 042 MKC-3946 blocks XBP1 mRNA splicingLY294002, CAS No. 154447 36 6, is a potent and selective small molecule PI3K inhibitor, inhibits PI3K with IC50 of 0. 5 M, 0. 57 M and 0. 97 M, respectively. It is the most widely used PI3K inhibitor to study the role of phosphoinositide 3 kinases in the signal transduction pathways involved in cell migration, proliferation, survival, and metabolism. LY294002 inactivates Akt PKB, consequently inhibiting cell proliferation and inducing apoptosis. It is
US$ 50.00
US$ 115.00
US$ 115.00
US$ 55.00
US$ 18.00
US$ 85.00
US$ 20.00
US$ 85.00
US$ 30.00
US$ 120.00
US$ 60.00